Chr. Olesen Revenue and Competitors

Gentofte,

Location

N/A

Total Funding

Chemicals

Industry

Estimated Revenue & Valuation

  • Chr. Olesen's estimated annual revenue is currently $15M per year.(i)
  • Chr. Olesen's estimated revenue per employee is $81,081

Employee Data

  • Chr. Olesen has 185 Employees.(i)
  • Chr. Olesen grew their employee count by 41% last year.

Chr. Olesen's People

NameTitleEmail/Phone
1
Managing PartnerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
N/A356%N/AN/A
#2
$7.5M21-38%N/AN/A
#3
$3.5M516%N/AN/A
#4
N/A1187%N/AN/A
#5
$1.7M356%N/AN/A
#6
N/A29-3%N/AN/A
#7
N/A62-3%N/AN/A
#8
$1.7M605%N/AN/A
#9
$15M150-6%N/AN/A
#10
N/A10%N/AN/A
Add Company

What Is Chr. Olesen?

We welcome you to Chr. Olesen. A family owned company established in 1885 in Denmark.             We have decades of experience in distributing ingredients to the Feed, Food and Pharma industries all over the world.Being a global company has not only taught us to focus on supplying the best products, but also to focus on delivering a dedicated and sincere service all around. From product quality and safety, with a knowledge of prices according to market conditions and trends - to efficient storage, a global delivery service and timely transportation. Our business is built on long term relationships and strategic partnerships with our customers and suppliers. As a customer and as a supplier you will encounter Chr. Olesen as a world class company that strives to improve the competitive edge of your business. Chr. Olesen - reliable since 1885

keywords:N/A

N/A

Total Funding

185

Number of Employees

$15M

Revenue (est)

41%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Chr. Olesen News

2022-04-13 - Planilha ajuda produtor a planejar plantio de árvores em ILPF ...

Desde 1º de Janeiro de 2022 a cadeia da produção de proteína animal no Brasil e América Latina conta com uma nova empresa, a NHU/Chr. Olesen...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$56.7M445-2%N/A